First product registrations in Peru signal potential revenue-generating opportunities

New product registration underscores the limited but increasing Latin American intraregional medical cannabis trade, independent from North American cannabis production.

Insurance-covered reimbursements for medical cannabis sets record in Germany

Insurance reimbursements for medical cannabis in Germany continue to reach fresh quarterly records, according to new data for the January-March period.

England’s medical cannabis market shows little growth as of early 2020

England’s medical cannabis market has barely gotten off the ground since launching about 19 months ago, with a two-tier system in which few patients access products through legal channels while most resort to illicit suppliers.

Brazil approves first medical cannabis product under 2019 regulations

Brazil’s health authorities authorized the first medical cannabis product registered under rules created in December 2019, marking an important milestone for the industry in Latin America’s largest economy.

Insurance-covered cannabis in Germany sets fourth-quarter record, pushing 2019 total to 123 million euros

Insurance reimbursements for medical cannabis in Germany reached a new high during the October-December period, propelling total reimbursements last year up nearly 70% from 2018, according to new data from the German National Association of Statutory Health Insurance Funds (GKV-Spitzenverband).

First medical cannabis sales in Colombia imminent – a year later than expected

Colombia’s delayed medical cannabis industry could see its first sale within days, according to one of the country’s leading producers.

German government doesn’t know how much cannabis sold in 2019, can’t estimate 2020 demand

The German federal government admitted that it doesn’t know how much medical cannabis was sold in the country in 2019.

Australia expects cannabis prescriptions will more than double to 70,000 this year

Australian health regulators expect the number of medical cannabis prescriptions will climb to at least 70,000 in 2020 at the current rate of growth, but local experts predict the final number could be much higher.

Australia expedites review of medical cannabis product Epidiolex

The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another.

GW Pharma beats projections with $108M in Q4 sales thanks to CBD drug

A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana.

As Brazil readies new cannabis regulatory framework, individual imports still growing strong

The cumulative number of authorizations for individual patients in Brazil to import nonregistered medical cannabis products exceeded 13,000 at the end of September 2019, according to data the country’s health regulator shared with Marijuana Business Daily.

2020 will demonstrate whether cannabis operators can transfer Colombia into marijuana powerhouse

Cannabis companies are wagering hundreds of millions of dollars on Colombia’s emerging cannabis industry, betting the Latin American country will become a major production and export hub.
But 2019 wasn’t the year in which these businesses began churning out medical cannabis products.